Recent News

572 News Items found
Illustration of cells with blue nuclei that have green DNA bits floating in the cytoplasm
In the Lab
Researchers have discovered that cancer cells may hijack an immune response to spread from a primary tumor to distant organs.
Three-dimensional reconstruction of the blood vessels in a mouse thymus using light-sheet fluorescent microscopy
In the Lab
Scientists have uncovered a molecule that, in mice, can promote the regeneration of the thymus, where T cells develop.
MP1104 binding to the kappa opioid receptor
Q&A
Science could lead to a new type of opioid drug that blocks pain but has a lower potential for addiction or abuse.
A barred Plymouth Rock hen
Feature
When this feathered patient found her way into a New York laboratory in 1909, she changed the course of cancer science.
Gears with 2016 and 2017
In the News
As 2017 draws to a close, take a look back at the scientific discoveries that deepened our understanding of cancer in the past year.
Sloan Kettering Institute Director Joan Massagué with laboratory member Karuna Ganesh
In the Lab
MSK investigators are learning how cancer cells escape from the original tumor and hide out in the body. Their goal is to prevent metastatic tumors from forming.
A microscopic view of genetically engineered mouse tumor and a human FL-HCC tumor
In the Lab
A team led by MSK molecular biologist Scott Lowe is making progress against fibrolamellar hepatocellular carcinoma.
Prostate cancer cells, colored red in scanning electron micrograph (SEM).
Science Byte
Researchers have discovered how a high level of the protein PSMA in cells helps fuel prostate cancer.
Former MSK president Paul Marks
Feature
Recent advances in epigenetic and targeted therapies owe a lot to the foresight of former MSK President Paul Marks, who believed in the importance of basic research.
Gad Getz, Chuan He, and Aviv Regev
Memorial Sloan Kettering (MSK) has named three investigators as recipients of this year’s Paul Marks Prize for Cancer Research. The award recognizes promising investigators aged 45 or younger at the time of nomination for their efforts in advancing cancer research.